# Curis Provides First Quarter 2026 Business Update
Canonical URL: https://biopharmsignal.com/news/CRIS/curis-provides-first-quarter-2026-business-update
Ticker: CRIS
Company: Curis Inc
Source: Curis Inc
Published: 2026-05-12 20:00 EST
Original Source URL: https://investors.curis.com
## Article Body
No article body is available yet.
## Recent Company News
- 2026-07-06 13:30 EST — [Curis Consents First Six Patients in TakeAim CLL Study](https://biopharmsignal.com/news/CRIS/curis-consents-first-six-patients-in-takeaim-cll-study-45969449) — Source: Curis Inc
- 2026-06-26 13:42 EST — [Curis Announces Eleven Active Clinical Sites in TakeAim CLL Study, Reaffirms Patient Dosing Guidance, and Reports Stockholder Approval of Reverse Stock Split](https://biopharmsignal.com/news/CRIS/curis-announces-eleven-active-clinical-sites-in-takeaim-cll-study-reaffirms-pati-978d906e) — Source: Curis Inc
- 2026-05-12 20:00 EST — [Curis Provides First Quarter 2026 Business Update](https://biopharmsignal.com/news/CRIS/curis-provides-first-quarter-2026-business-update) — Source: Curis Inc
- 2026-05-05 21:11 EST — [Curis to Report First Quarter 2026 Financial and Operating Results and Host Conference Call and Webcast on May 12, 2026](https://biopharmsignal.com/news/CRIS/curis-to-report-first-quarter-2026-financial-and-operating-results-and-host-conference-call-and-webcast-on-may-12-2026) — Source: Curis
- 2026-03-19 20:00 EST — [Curis Provides Fourth Quarter 2025 Business Update](https://biopharmsignal.com/news/CRIS/curis-provides-fourth-quarter-2025-business-update) — Source: Curis Inc
## Related News
- 2026-07-21 12:05 EST — VRCA — [Verrica Pharmaceuticals and Medomie Pharma Enter into Exclusive Distribution, Marketing and Supply Agreement to Commercialize YCANTH® for the Treatment of Molluscum Contagiosum in Israel](https://biopharmsignal.com/news/VRCA/verrica-pharmaceuticals-and-medomie-pharma-enter-into-exclusive-distribution-mar-abf61522)
- 2026-07-21 11:30 EST — ABEO — [Cincinnati Children's Activated as the Seventh Qualified Treatment Center for ZEVASKYN®](https://biopharmsignal.com/news/ABEO/cincinnati-children-s-activated-as-the-seventh-qualified-treatment-center-for-ze-8382d043)
- 2026-07-21 10:28 EST — GSK — [ViiV Healthcare to present phase IIIb data comparing Dovato with Biktarvy in treatment-naïve adults alongside INSTI-powered long-acting injectable innovation at AIDS 2026](https://biopharmsignal.com/news/GSK/viiv-healthcare-to-present-phase-iiib-data-comparing-dovato-with-biktarvy-in-tre-1ff3f640)
- 2026-07-20 20:05 EST — RANI — [Rani Therapeutics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)](https://biopharmsignal.com/news/RANI/rani-therapeutics-reports-inducement-grant-under-nasdaq-listing-rule-5635-c-4-ec56b3b0)
- 2026-07-20 14:53 EST — IPHA — [Innate Pharma announces Completion of Enrollment in Phase 1 Dose Escalation Study of IPH4502, a Novel Nectin-4 Exatecan Antibody-Drug Conjugate (ADC)](https://biopharmsignal.com/news/IPHA/innate-pharma-announces-completion-of-enrollment-in-phase-1-dose-escalation-stud-0778493f)